Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18451-18500 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02992522
Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
22 participants
Started: Feb 21, 2017 · Completed: Aug 15, 2026
13 conditions
3 sponsors
2 locations
NCT03191682
A First-in-Human Study of PRL3-ZUMAB
PHASE1
Active, not recruiting
38 participants
Started: Feb 20, 2017 · Completed: Feb 20, 2027
1 condition
2 sponsors
1 location
NCT03068442
The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition
PHASE2
Active, not recruiting
45 participants
Started: Feb 17, 2017 · Completed: Sep 10, 2024
3 conditions
2 sponsors
2 locations
NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
PHASE2
Active, not recruiting
14 participants
Started: Feb 16, 2017 · Completed: Jul 31, 2025
9 conditions
1 sponsor
3 locations
NCT03069469
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Feb 16, 2017 · Completed: Aug 31, 2028
5 conditions
1 sponsor
24 locations
NCT03180216
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
PHASE1
Active, not recruiting
32 participants
Started: Feb 15, 2017 · Completed: Nov 30, 2026
2 conditions
1 sponsor
1 location
NCT03066297
Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer
N/A
Active, not recruiting
1,018 participants
Started: Feb 15, 2017 · Completed: Feb 15, 2027
1 condition
1 sponsor
1 location
NCT02956291
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
NA
Active, not recruiting
172 participants
Started: Feb 15, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03121248
Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years
NA
Active, not recruiting
144 participants
Started: Feb 15, 2017 · Completed: Nov 15, 2026
1 condition
1 sponsor
1 location
NCT02923180
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
PHASE2
Active, not recruiting
33 participants
Started: Feb 14, 2017 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT02843633
LEADERS FREE II: BioFreedom™ Pivotal Study
NA
Active, not recruiting
1,203 participants
Started: Feb 14, 2017 · Completed: Mar 31, 2021
2 conditions
1 sponsor
66 locations
NCT02816021
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
PHASE2
Active, not recruiting
24 participants
Started: Feb 14, 2017 · Completed: Feb 28, 2026
2 conditions
3 sponsors
1 location
NCT03015896
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
36 participants
Started: Feb 14, 2017 · Completed: Dec 31, 2026
15 conditions
2 sponsors
2 locations
NCT03052985
Materiovigilance After Urinary Incontinence or Prolapse Surgery
N/A
Active, not recruiting
19,000 participants
Started: Feb 14, 2017 · Completed: May 1, 2033
3 conditions
2 sponsors
31 locations
NCT03078010
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
PHASE2
Active, not recruiting
347 participants
Started: Feb 10, 2017 · Completed: Feb 28, 2026
2 conditions
1 sponsor
2 locations
NCT02981940
A Study of Abemaciclib in Recurrent Glioblastoma
PHASE2
Active, not recruiting
45 participants
Started: Feb 9, 2017 · Completed: Jun 30, 2026
1 condition
2 sponsors
7 locations
NCT02950259
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
PHASE1
Active, not recruiting
16 participants
Started: Feb 9, 2017 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT03034811
Persona Partial Knee Clinical Outcomes Study
NA
Active, not recruiting
643 participants
Started: Feb 8, 2017 · Completed: Jul 31, 2029
5 conditions
1 sponsor
24 locations
NCT03035409
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
PHASE2
Active, not recruiting
129 participants
Started: Feb 8, 2017 · Completed: Feb 28, 2026
6 conditions
2 sponsors
1 location
NCT03031262
Efficacy and Safety of Chidamide in CBF Leukemia
PHASE1/PHASE2
Active, not recruiting
250 participants
Started: Feb 8, 2017 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT03021330
Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
PHASE3
Active, not recruiting
1,100 participants
Started: Feb 8, 2017 · Completed: Oct 15, 2027
1 condition
1 sponsor
1 location
NCT05848024
EBRA Study AMISTEM-C FR
N/A
Active, not recruiting
100 participants
Started: Feb 8, 2017 · Completed: Feb 28, 2029
1 condition
1 sponsor
1 location
NCT02836899
Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
PHASE3
Active, not recruiting
250 participants
Started: Feb 8, 2017 · Completed: Dec 31, 2025
1 condition
15 sponsors
1 location
NCT02960555
Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
PHASE2
Active, not recruiting
61 participants
Started: Feb 8, 2017 · Completed: Apr 30, 2030
1 condition
2 sponsors
3 locations
NCT04651465
Norwegian Tuning in to Kids Effectivity Study
NA
Active, not recruiting
431 participants
Started: Feb 7, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03049007
The Aarhus Bereavement Study
N/A
Active, not recruiting
1,243 participants
Started: Feb 7, 2017 · Completed: Apr 1, 2030
1 condition
1 sponsor
1 location
NCT02775851
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
PHASE2
Active, not recruiting
57 participants
Started: Feb 6, 2017 · Completed: May 15, 2026
1 condition
1 sponsor
281 locations
NCT03044704
Haemodynamic and Geometric Factors in Atherosclerosis
N/A
Active, not recruiting
100 participants
Started: Feb 6, 2017 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT02975661
Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery
N/A
Active, not recruiting
740 participants
Started: Feb 4, 2017 · Completed: Feb 29, 2024
1 condition
3 sponsors
12 locations
NCT03047265
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2
Active, not recruiting
164 participants
Started: Feb 4, 2017 · Completed: Jun 1, 2027
1 condition
1 sponsor
1 location
NCT03049189
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
PHASE3
Active, not recruiting
309 participants
Started: Feb 2, 2017 · Completed: Nov 30, 2029
1 condition
3 sponsors
52 locations
NCT02970318
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
PHASE3
Active, not recruiting
310 participants
Started: Feb 2, 2017 · Completed: Oct 1, 2027
1 condition
1 sponsor
157 locations
NCT02993523
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
PHASE3
Active, not recruiting
443 participants
Started: Feb 2, 2017 · Completed: Jan 23, 2026
1 condition
2 sponsors
172 locations
NCT06862037
Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication
N/A
Active, not recruiting
112 participants
Started: Feb 1, 2017 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT03315312
Occlusal Caries Management in First Permanent Molars in Child Dental Care
PHASE4
Active, not recruiting
410 participants
Started: Feb 1, 2017 · Completed: Dec 31, 2023
2 conditions
4 sponsors
1 location
NCT02649166
Responsive Deep Brain Stimulator for Essential Tremor
NA
Active, not recruiting
20 participants
Started: Feb 1, 2017 · Completed: Jun 30, 2027
1 condition
3 sponsors
1 location
NCT03049202
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
N/A
Active, not recruiting
1,000 participants
Started: Feb 1, 2017 · Completed: Dec 31, 2030
6 conditions
14 sponsors
6 locations
NCT03049553
Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls
NA
Active, not recruiting
7,000 participants
Started: Feb 1, 2017 · Completed: Dec 31, 2025
1 condition
6 sponsors
1 location
NCT03047746
Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
NA
Active, not recruiting
50 participants
Started: Feb 1, 2017 · Completed: May 31, 2029
3 conditions
1 sponsor
1 location
NCT03004118
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
PHASE4
Active, not recruiting
16 participants
Started: Jan 31, 2017 · Completed: Nov 30, 2025
1 condition
1 sponsor
0 locations
NCT02959021
Partnership Optimizes Weight Management in Primary Care
NA
Active, not recruiting
375 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02979587
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
NA
Active, not recruiting
86 participants
Started: Jan 31, 2017 · Completed: Feb 28, 2031
4 conditions
1 sponsor
12 locations
NCT02870517
Pre-operative Stress Reduction With Music
NA
Active, not recruiting
212 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02860975
Prolonged Hypoxic Breathing in Healthy Volunteers: a Safety Study
NA
Active, not recruiting
12 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2025
1 condition
10 sponsors
1 location
NCT02682511
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
PHASE2
Active, not recruiting
34 participants
Started: Jan 31, 2017 · Completed: May 31, 2026
8 conditions
1 sponsor
13 locations
NCT02871089
Closed Loop From Onset in Type 1 Diabetes
NA
Active, not recruiting
96 participants
Started: Jan 31, 2017 · Completed: Jul 31, 2024
2 conditions
9 sponsors
7 locations
NCT03006068
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
PHASE3
Active, not recruiting
950 participants
Started: Jan 31, 2017 · Completed: Jul 31, 2027
1 condition
1 sponsor
492 locations
NCT04058431
Osteopathic Manipulation Makes a Neuropsychological Difference
NA
Active, not recruiting
100 participants
Started: Jan 31, 2017 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT02973386
Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
PHASE3
Active, not recruiting
278 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03019081
Augmented Interoceptive Exposure Training in Anorexia Nervosa
NA
Active, not recruiting
25 participants
Started: Jan 31, 2017 · Completed: Nov 30, 2024
1 condition
2 sponsors
1 location
Previous
1
More pages
367
368
369
370
371
372
373
More pages
431
Next